Evidence map›Paper›PMID 32579581›Full record

ArticlePLoS genetics2020

Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction.

Chung-Yang Kao, Mafei Xu, Leiming Wang, Shih-Chieh Lin, Hui-Ju Lee, Lita Duraine, Hugo J Bellen, David S Goldstein, Sophia Y Tsai, Ming-Jer Tsai

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Insights into Neurodegeneration in Parkinson's Disease from Single-Cell and Spatial Genomics.Movement disorders : official journal of the Movement Disorder Society · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Mediators of inflammation · 2022
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Chung-Yang KaoDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Mafei XuDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.ORCID 0000-0002-9064-7371
Leiming WangDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Shih-Chieh LinInstitute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.ORCID 0000-0002-9967-5037
Hui-Ju LeeDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Lita DuraineDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
Hugo J BellenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
David S GoldsteinClinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America.
Sophia Y TsaiDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
Ming-Jer TsaiDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, United States of America.ORCID 0000-0001-6287-908X
Baylor College of Medicine · USHoward Hughes Medical Institute · USNational Cheng Kung University · TWNational Institutes of Health · US

Funding

Mechanisms of Parkinson Disease and Related DisordersZIANS003033 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI GOLDSTEIN, DAVID · 2009 to 2022
$8.2M
Nuclear Orphan Receptor, COUP-TFII, in Energy Metabolism and DiseaseR01HL114539 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI TSAI, SOPHIA Y. · 2013 to 2016
$1.5M
NHLBI NIH HHS R01 HL114539
6 · The paper itself

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder featuring progressive loss of midbrain dopaminergic (DA) neurons that leads to motor symptoms. The etiology and pathogenesis of PD are not clear. We found that expression of COUP-TFII, an orphan nuclear receptor, in DA neurons is upregulated in PD patients through the analysis of public datasets. We show here that through epigenetic regulation, COUP-TFII contributes to oxidative stress, suggesting that COUP-TFII may play a role in PD pathogenesis. Elevated COUP-TFII expression specifically in DA neurons evokes DA neuronal loss in mice and accelerates the progression of phenotypes in a PD mouse model, MitoPark. Compared to control mice, those with elevated COUP-TFII expression displayed reduced cristae in mitochondria and enhanced cellular electron-dense vacuoles in the substantia nigra pars compacta. Mechanistically, we found that overexpression of COUP-TFII disturbs mitochondrial pathways, resulting in mitochondrial dysfunction. In particular, there is repressed expression of genes encoding cytosolic aldehyde dehydrogenases, which could enhance oxidative stress and interfere with mitochondrial function via 3,4-dihydroxyphenylacetaldehyde (DOPAL) buildup in DA neurons. Importantly, under-expression of COUP-TFII in DA neurons slowed the deterioration in motor functions of MitoPark mice. Taken together, our results suggest that COUP-TFII may be an important contributor to PD development and a potential therapeutic target.

Indexed as

3,4-Dihydroxyphenylacetic AcidAldehyde DehydrogenaseAnimalsBrainCell LineCell Line, TumorCohort StudiesCOUP Transcription Factor IIDatasets as TopicDisease Models, AnimalDisease ProgressionDopaminergic NeuronsFemaleHumansMaleMice3,4-dihydroxyphenylacetaldehyde3,4-Dihydroxyphenylacetic AcidAldehyde DehydrogenaseCOUP Transcription Factor IINR2F2 protein, humanNr2f2 protein, mouseNr2f2 protein, rat

Identifiers

PMID32579581
PMCPMC7340320
OpenAlexW3038029987

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.